Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas A Jabs, MD, MBA
Center for Clinical Trials and Evidence Synthesis, JHU, Baltimore, MD
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Victorian Eye and Ear Hospital
East Melbourne, Victoria, Australia
- Mcgill University
Montreal, Quebec, Canada
- Lv Prasad Eye Institute - Bhubaneswar
Bhubaneswar, Odisha, India
- Medical and Vision Research Foundation
Chennai, Tamil Nadu, India
- Lv Prasad Eye Institute - Hyderabad
Hyderabad, Telangana, India
- Advanced Eye Center, Post Graduate Institute of Medical Education and Research
Chandigarh, India
- University Hospitals Bristol Nhs Foundation Trust
Bristol, England, United Kingdom
- Cambridge University Hospitals Nhs Foundation Trust
Cambridge, England, United Kingdom
- University Hospitals of Leicester Nhs Trust
Leicester, England, United Kingdom
- Liverpool University Hospitals Nhs Foundation Trust
Liverpool, England, United Kingdom
- Moorfields Eye Hospital Nhs Foundation Trust
London, England, United Kingdom
- Manchester University Nhs Foundation Trust
Manchester, England, United Kingdom
- University Hospitals Birmingham Nhs Foundation Trust
Birmingham, United Kingdom
- Moorfields Eye Hospital
London, United Kingdom
- Jules Stein Eye Institute, Ucla
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Louisville
Louisville, Kentucky, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- Kellogg Eye Center, University of Michigan
Ann Arbor, Michigan, United States
- Duke Eye Center, Duke University
Durham, North Carolina, United States
- Midatlanitc Retina, Wills Eye Hospital
Philadelphia, Pennsylvania, United States
- Scheie Eye Institute, University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt
Nashville, Tennessee, United States
- Retinal Consultants of Houston
Houston, Texas, United States
- John A. Moran Eye Center, University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Mar 2017
- Primary completion
- 27 Oct 2021
- Completion
- 2 Feb 2022
- Last update posted
- 10 Jul 2023
- Registered enrollment
- 194
- Registry id
- NCT02623426
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.